---
layout: default
title: Famotidine
description: "Famotidine çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 69
evidence_level: L1
indication_count: 10
---

# Famotidine

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Famotidine è—¥å¸«è©•ä¼°ç­†è¨˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Famotidine å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Famotidine æ˜¯ H2 å—é«”æ‹®æŠ—åŠ‘ï¼ŒTxGNN é æ¸¬å…¶å¯ç”¨æ–¼åäºŒæŒ‡è…¸èƒƒé£Ÿé“é€†æµå’Œæ¶ˆåŒ–æ€§æ½°ç˜ï¼Œé€™äº›é æ¸¬èˆ‡åŸæ ¸å‡†é©æ‡‰ç—‡é«˜åº¦é‡ç–Šï¼Œå…·æœ‰å……åˆ†çš„è‡¨åºŠè­‰æ“šæ”¯æŒã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Famotidine (æ³•è«æ›¿ä¸) |
| DrugBank ID | DB00927 |
| å°ç£å•†å“å | è«¾å¾—èˆ’èƒƒç¦æ²»æ½°è†œè¡£éŒ  |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | èƒƒæ½°ç˜ã€åäºŒæŒ‡è…¸æ½°ç˜ã€é€†æµæ€§é£Ÿé“ç‚ã€Zollinger-Ellison ç—‡å€™ç¾¤ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | peptic esophagitisã€gastrin secretion abnormalityã€duodenogastric refluxã€duodenal obstructionã€duodenal ulcer (disease)ã€active peptic ulcer diseaseã€peptic ulcer perforationã€gastrojejunal ulcerã€esophagitis (disease)ã€Zollinger-Ellison syndrome |
| æœ€é«˜é æ¸¬åˆ†æ•¸ | 0.9999 (duodenogastric reflux) |
| è­‰æ“šç­‰ç´š | L2 (å–®ä¸€ RCT/å¤šå€‹ Phase 2) |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. duodenogastric reflux</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Famotidine çš„é æ¸¬é©æ‡‰ç—‡èˆ‡å…¶å·²çŸ¥è—¥ç†æ©Ÿè½‰é«˜åº¦ä¸€è‡´ï¼š</p>

<ol>
<li><strong>èƒƒé…¸æŠ‘åˆ¶æ©Ÿè½‰</strong>ï¼šH2 å—é«”æ‹®æŠ—åŠ‘å¯æ¸›å°‘èƒƒé…¸åˆ†æ³Œï¼Œæ˜¯æ²»ç™‚æ¶ˆåŒ–æ€§æ½°ç˜çš„ç¶“å…¸æ©Ÿè½‰</li>
<li><strong>é»è†œä¿è­·</strong>ï¼šæ¸›å°‘èƒƒé…¸å¯é™ä½èƒƒé»è†œæå‚·ï¼Œä¿ƒé€²æ½°ç˜ç™’åˆ</li>
<li><strong>é©æ‡‰ç—‡é‡ç–Š</strong>ï¼šé æ¸¬çš„é©æ‡‰ç—‡å¯¦éš›ä¸Šæ˜¯åŸæ ¸å‡†é©æ‡‰ç—‡çš„å»¶ä¼¸æˆ–ç´°åˆ†</li>
<li><strong>è‡¨åºŠå¯¦å‹™ä¸€è‡´</strong>ï¼šé€™äº›é æ¸¬åæ˜ äº† famotidine çš„å¯¦éš›è‡¨åºŠä½¿ç”¨ç¯„åœ</li>
</ol>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

<h3>ç›¸é—œæ–‡ç»</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12532466/" target="_blank">12532466</a></td><td>2003</td><td>Article</td><td>World journal of gastroenterol</td><td>The effect of famotidine on gastroesophageal and duodeno-gastro-esophageal reflu...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16259441/" target="_blank">16259441</a></td><td>2004</td><td>Article</td><td>Eksperimental&#x27;naia i kliniches</td><td>[H2-blockers of histamine receptors in the therapy of early stages of gastroduod...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. duodenal obstruction</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ2 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00450216" target="_blank">NCT00450216</a></td><td>PHASE3</td><td>COMPLETED</td><td>906</td><td>A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00450658" target="_blank">NCT00450658</a></td><td>PHASE3</td><td>COMPLETED</td><td>627</td><td>A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 ...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ3 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8165479/" target="_blank">8165479</a></td><td>1994</td><td>Article</td><td>Surgical endoscopy</td><td>Giant marginal ulcer.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9306611/" target="_blank">9306611</a></td><td>1997</td><td>Article</td><td>Surgery today</td><td>Surgical treatment for duodenal involvement in Crohn&#x27;s disease: report of a case...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2816881/" target="_blank">2816881</a></td><td>1989</td><td>Article</td><td>The American journal of gastro</td><td>Failure of single night-time dose of H2-receptor antagonists in the treatment of...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. active peptic ulcer disease</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ19 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9506245/" target="_blank">9506245</a></td><td>1998</td><td>Article</td><td>Drugs</td><td>Rabeprazole.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2905237/" target="_blank">2905237</a></td><td>1988</td><td>Article</td><td>Drugs</td><td>Prostaglandins, H2-receptor antagonists and peptic ulcer disease.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3310199/" target="_blank">3310199</a></td><td>1987</td><td>Article</td><td>Scandinavian journal of gastro</td><td>Ulcer pain mechanisms. The clinical features of active peptic ulcer disease and ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34798155/" target="_blank">34798155</a></td><td>2022</td><td>Article</td><td>International journal of pharm</td><td>Famotidine-loaded solid self-nanoemulsifying drug delivery system demonstrates e...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39345794/" target="_blank">39345794</a></td><td>2024</td><td>Article</td><td>Toxicology research</td><td>Diospyros kaki fruit aqueous extract individual/combined with famotidine mitigat...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2889257/" target="_blank">2889257</a></td><td>1987</td><td>Article</td><td>Scandinavian journal of gastro</td><td>Clinical benefits of intravenously administered famotidine in the treatment of u...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25926722/" target="_blank">25926722</a></td><td>2015</td><td>Article</td><td>Drug design, development and t</td><td>Evaluation of combined famotidine with quercetin for the treatment of peptic ulc...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2877912/" target="_blank">2877912</a></td><td>1987</td><td>Article</td><td>Gastroenterology</td><td>A multicenter, double-blind, randomized, placebo-controlled comparison of noctur...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8865446/" target="_blank">8865446</a></td><td>1996</td><td>Article</td><td>Scandinavian journal of gastro</td><td>A review on treatment of bleeding peptic ulcer: a collaborative task of gastroen...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26283843/" target="_blank">26283843</a></td><td>2015</td><td>Article</td><td>Journal of natural science, bi</td><td>Protective effects of ginger and marshmallow extracts on indomethacin-induced pe...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1863945/" target="_blank">1863945</a></td><td>1991</td><td>Article</td><td>Clinical therapeutics</td><td>The efficacy and tolerability of famotidine and ranitidine on the healing of act...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7594320/" target="_blank">7594320</a></td><td>1995</td><td>Article</td><td>Journal of clinical gastroente</td><td>Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazol...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1976583/" target="_blank">1976583</a></td><td>1990</td><td>Article</td><td>Hepato-gastroenterology</td><td>Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/27888865/" target="_blank">27888865</a></td><td>2016</td><td>Article</td><td>Gastroenterologia y hepatologi</td><td>Advances in gastrointestinal bleeding.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2877570/" target="_blank">2877570</a></td><td>1986</td><td>Article</td><td>The American journal of medici</td><td>A multicenter, randomized, double-blind study comparing famotidine with ranitidi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2570005/" target="_blank">2570005</a></td><td>1989</td><td>Article</td><td>Digestion</td><td>A multicenter, randomized, double-blind study comparing famotidine with cimetidi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2670647/" target="_blank">2670647</a></td><td>1989</td><td>Article</td><td>Digestion</td><td>A multicenter, randomized, double-blind study comparing a daily bedtime administ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1420739/" target="_blank">1420739</a></td><td>1992</td><td>Article</td><td>Alimentary pharmacology &amp; ther</td><td>Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disea...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9690716/" target="_blank">9690716</a></td><td>1998</td><td>Article</td><td>Prostaglandins, leukotrienes, </td><td>Hypothesis: cis-unsaturated fatty acids as potential anti-peptic ulcer drugs.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. peptic ulcer perforation</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ2 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00683111" target="_blank">NCT00683111</a></td><td>PHASE4</td><td>COMPLETED</td><td>500</td><td>Famotidine Compared With Esomeprazole in the Prevention of Ulcer Complications i...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00450658" target="_blank">NCT00450658</a></td><td>PHASE3</td><td>COMPLETED</td><td>627</td><td>A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 ...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ9 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8165479/" target="_blank">8165479</a></td><td>1994</td><td>Article</td><td>Surgical endoscopy</td><td>Giant marginal ulcer.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19837071/" target="_blank">19837071</a></td><td>2010</td><td>Article</td><td>Gastroenterology</td><td>Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-relat...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/21954519/" target="_blank">21954519</a></td><td>2011</td><td>Article</td><td>Prescrire international</td><td>Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at hig...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10379475/" target="_blank">10379475</a></td><td>1999</td><td>Article</td><td>Italian journal of gastroenter</td><td>A clinical approach to management of patients with non-steroidal anti-inflammato...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/21387691/" target="_blank">21387691</a></td><td>2011</td><td>Article</td><td>Nihon rinsho. Japanese journal</td><td>[Strategy to manage low dose aspirin-induced gastrointestinal injury].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10063300/" target="_blank">10063300</a></td><td>1998</td><td>Article</td><td>Journal of the Indian Medical </td><td>Simple closure of perforated duodenal ulcer.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12658910/" target="_blank">12658910</a></td><td>2003</td><td>Article</td><td>Wiener klinische Wochenschrift</td><td>[Adverse effects of non-steroidal anti-inflammatory drugs. A prevalence study in...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2500018/" target="_blank">2500018</a></td><td>1989</td><td>Article</td><td>The American journal of medici</td><td>Sucralfate in the prevention of porcine experimental peptic ulceration.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19391208/" target="_blank">19391208</a></td><td>2009</td><td>Article</td><td>Khirurgiia</td><td>[Antisecretory therapy strategy for patients with bleeding and perforated gastro...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. gastrojejunal ulcer</span>
<span class="evidence-badge evidence-L2">L2</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ1 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00557349" target="_blank">NCT00557349</a></td><td>PHASE4</td><td>COMPLETED</td><td>40</td><td>A Randomized, Double-blind Clinical Trial Comparing Zegerid Capsule to Famotidin...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35348552/" target="_blank">35348552</a></td><td>2022</td><td>Article</td><td>The Medical letter on drugs an</td><td>Drugs for GERD and peptic ulcer disease.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2028638/" target="_blank">2028638</a></td><td>1991</td><td>Article</td><td>DICP : the annals of pharmacot</td><td>Famotidine and cardiac arrhythmia.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8853932/" target="_blank">8853932</a></td><td>1996</td><td>Article</td><td>Clinical pharmacokinetics</td><td>Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2892567/" target="_blank">2892567</a></td><td>1988</td><td>Article</td><td>British medical journal (Clini</td><td>Peptic ulceration.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2875864/" target="_blank">2875864</a></td><td>1986</td><td>Article</td><td>Drugs</td><td>Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary rev...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16437673/" target="_blank">16437673</a></td><td>2005</td><td>Article</td><td>World journal of gastroenterol</td><td>Synergistic action of famotidine and chlorpheniramine on acetic acid-induced chr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2573505/" target="_blank">2573505</a></td><td>1989</td><td>Article</td><td>Drugs</td><td>Famotidine. An updated review of its pharmacodynamic and pharmacokinetic propert...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2979698/" target="_blank">2979698</a></td><td>1987</td><td>Article</td><td>Alimentary pharmacology &amp; ther</td><td>The place of famotidine in anti-ulcer therapy.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1428035/" target="_blank">1428035</a></td><td>1992</td><td>Article</td><td>Indian journal of gastroentero</td><td>Comparative study of omeprazole and famotidine in the treatment of duodenal ulce...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7594320/" target="_blank">7594320</a></td><td>1995</td><td>Article</td><td>Journal of clinical gastroente</td><td>Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazol...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8218758/" target="_blank">8218758</a></td><td>1993</td><td>Article</td><td>Alimentary pharmacology &amp; ther</td><td>Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7594335/" target="_blank">7594335</a></td><td>1995</td><td>Article</td><td>Journal of clinical gastroente</td><td>Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultras...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22273212/" target="_blank">22273212</a></td><td>2011</td><td>Article</td><td>The American surgeon</td><td>Famotidine use and thrombocytopenia in the trauma patient.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11943947/" target="_blank">11943947</a></td><td>2002</td><td>Article</td><td>European journal of gastroente</td><td>Effects of omeprazole and famotidine on fibroblast growth factor-2 during artifi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8835890/" target="_blank">8835890</a></td><td>1996</td><td>Article</td><td>Journal of clinical gastroente</td><td>Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26165391/" target="_blank">26165391</a></td><td>2015</td><td>Article</td><td>The Physician and sportsmedici</td><td>Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ib...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3075106/" target="_blank">3075106</a></td><td>1988</td><td>Article</td><td>Acta gastroenterologica Latino</td><td>Famotidine in the short and long-term treatment of duodenal ulcer.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25521726/" target="_blank">25521726</a></td><td>2014</td><td>Article</td><td>Journal of gastroenterology an</td><td>Comparison of teprenone and famotidine against gastroduodenal mucosal damage in ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2901868/" target="_blank">2901868</a></td><td>1988</td><td>Article</td><td>Bailliere&#x27;s clinical gastroent</td><td>Histamine H2-receptor antagonists.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1764869/" target="_blank">1764869</a></td><td>1991</td><td>Article</td><td>Clinical pharmacokinetics</td><td>Clinical pharmacokinetics of famotidine.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. abnormality of glucagon secretion</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.91%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. gastroduodenitis</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.80%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25521726/" target="_blank">25521726</a></td><td>2014</td><td>Article</td><td>Journal of gastroenterology an</td><td>Comparison of teprenone and famotidine against gastroduodenal mucosal damage in ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9178671/" target="_blank">9178671</a></td><td>1997</td><td>Article</td><td>Gastroenterology</td><td>Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-as...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7846741/" target="_blank">7846741</a></td><td>1994</td><td>Article</td><td>Therapeutic drug monitoring</td><td>Pharmacokinetics and pharmacodynamics of famotidine in children with gastroduode...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22066725/" target="_blank">22066725</a></td><td>2012</td><td>Article</td><td>Neurogastroenterology and moti</td><td>Influence of gastric acid on gastric emptying and gastric distension-induced pai...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14653238/" target="_blank">14653238</a></td><td>2003</td><td>Article</td><td>Eksperimental&#x27;naia i kliniches</td><td>[Laser therapy and famotidine in complex restorative treatment of primary chroni...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24531083/" target="_blank">24531083</a></td><td>2014</td><td>Article</td><td>Internal medicine (Tokyo, Japa</td><td>Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induc...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10321752/" target="_blank">10321752</a></td><td>1999</td><td>Article</td><td>European journal of gastroente</td><td>Toxicity of NSAIDs in the stomach and duodenum.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2905237/" target="_blank">2905237</a></td><td>1988</td><td>Article</td><td>Drugs</td><td>Prostaglandins, H2-receptor antagonists and peptic ulcer disease.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32020689/" target="_blank">32020689</a></td><td>2020</td><td>Article</td><td>Journal of veterinary internal</td><td>Comparative analysis of the effect of IV administered acid suppressants on gastr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22388022/" target="_blank">22388022</a></td><td>2012</td><td>Article</td><td>The American journal of gastro</td><td>Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31229990/" target="_blank">31229990</a></td><td>2020</td><td>Article</td><td>Gut</td><td>Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11827362/" target="_blank">11827362</a></td><td>2001</td><td>Article</td><td>Digestive and liver disease : </td><td>Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/15704743/" target="_blank">15704743</a></td><td>2004</td><td>Article</td><td>Khirurgiia</td><td>[Study on the efficacy of famotidine (Quamatel) in the complex treatment of eros...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10203432/" target="_blank">10203432</a></td><td>1999</td><td>Article</td><td>Canadian journal of gastroente</td><td>Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8165833/" target="_blank">8165833</a></td><td>1994</td><td>Article</td><td>Zeitschrift fur Gastroenterolo</td><td>[High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of a...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2129490/" target="_blank">2129490</a></td><td>1990</td><td>Article</td><td>Alimentary pharmacology &amp; ther</td><td>NSAID-associated gastroduodenal damage: does famotidine protection extend into t...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7970643/" target="_blank">7970643</a></td><td>1994</td><td>Article</td><td>Orvosi hetilap</td><td>[Famotidine in the treatment of gastroduodenal ulcer].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1783354/" target="_blank">1783354</a></td><td>1991</td><td>Article</td><td>Fukuoka igaku zasshi = Hukuoka</td><td>Effects of combination therapy with pirenzepine and famotidine on tetragastrin-s...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40323256/" target="_blank">40323256</a></td><td>2025</td><td>Article</td><td>Biomarkers : biochemical indic</td><td>Aqueous Pistacia lentiscus leaves extract protects against ethanol-induced gastr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10392669/" target="_blank">10392669</a></td><td>1999</td><td>Article</td><td>Drug safety</td><td>Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. peptic ulcer disease</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.72%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ14 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00683111" target="_blank">NCT00683111</a></td><td>PHASE4</td><td>COMPLETED</td><td>500</td><td>Famotidine Compared With Esomeprazole in the Prevention of Ulcer Complications i...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03667703" target="_blank">NCT03667703</a></td><td>PHASE4</td><td>COMPLETED</td><td>70</td><td>Stress Ulcer Prophylaxis Versus Placebo - a Blinded Randomized Control Trial to ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00839488" target="_blank">NCT00839488</a></td><td>PHASE4</td><td>TERMINATED</td><td>6</td><td>Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylax...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01180179" target="_blank">NCT01180179</a></td><td>PHASE4</td><td>COMPLETED</td><td>228</td><td>Prevention of Recurrent Idiopathic Gastroduodenal Ulcer Bleeding: a Double-blind...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00229424" target="_blank">NCT00229424</a></td><td>PHASE3</td><td>COMPLETED</td><td>325</td><td>Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Cont...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02551744" target="_blank">NCT02551744</a></td><td>NA</td><td>COMPLETED</td><td>101</td><td>Pantoprazole Versus Famotidine for the Prevention of Recurrent Peptic Ulcers in ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00978159" target="_blank">NCT00978159</a></td><td>PHASE4</td><td>UNKNOWN</td><td>128</td><td>Esomeprazole or Famotidine in the Management of Aspirin Related Non-ulcer Dyspep...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01408186" target="_blank">NCT01408186</a></td><td>PHASE3</td><td>COMPLETED</td><td>264</td><td>Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02418312" target="_blank">NCT02418312</a></td><td>NA</td><td>COMPLETED</td><td>228</td><td>Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Pepti...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00153673" target="_blank">NCT00153673</a></td><td>PHASE3</td><td>COMPLETED</td><td>200</td><td>Phase III Study of a Double-Blind Randomized Comparison of Famotidine Plus Celec...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00843063" target="_blank">NCT00843063</a></td><td>PHASE4</td><td>COMPLETED</td><td>161</td><td>Famotidine vs. Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Er...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04123899" target="_blank">NCT04123899</a></td><td>NA</td><td>UNKNOWN</td><td>32</td><td>An Open-Label, Randomized, Two-sequence, Two-period, Fasting Condition, Single O...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00557349" target="_blank">NCT00557349</a></td><td>PHASE4</td><td>COMPLETED</td><td>40</td><td>A Randomized, Double-blind Clinical Trial Comparing Zegerid Capsule to Famotidin...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00450658" target="_blank">NCT00450658</a></td><td>PHASE3</td><td>COMPLETED</td><td>627</td><td>A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 ...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35348552/" target="_blank">35348552</a></td><td>2022</td><td>Article</td><td>The Medical letter on drugs an</td><td>Drugs for GERD and peptic ulcer disease.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2573505/" target="_blank">2573505</a></td><td>1989</td><td>Article</td><td>Drugs</td><td>Famotidine. An updated review of its pharmacodynamic and pharmacokinetic propert...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2875864/" target="_blank">2875864</a></td><td>1986</td><td>Article</td><td>Drugs</td><td>Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary rev...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2905237/" target="_blank">2905237</a></td><td>1988</td><td>Article</td><td>Drugs</td><td>Prostaglandins, H2-receptor antagonists and peptic ulcer disease.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34798155/" target="_blank">34798155</a></td><td>2022</td><td>Article</td><td>International journal of pharm</td><td>Famotidine-loaded solid self-nanoemulsifying drug delivery system demonstrates e...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2869852/" target="_blank">2869852</a></td><td>1986</td><td>Article</td><td>Clinical pharmacy</td><td>Current concepts in clinical therapeutics: peptic ulcer disease.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2892567/" target="_blank">2892567</a></td><td>1988</td><td>Article</td><td>British medical journal (Clini</td><td>Peptic ulceration.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3061768/" target="_blank">3061768</a></td><td>1988</td><td>Article</td><td>Drugs</td><td>The significance of gastrin in the pathogenesis and therapy of peptic ulcer dise...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7551483/" target="_blank">7551483</a></td><td>1995</td><td>Article</td><td>British journal of hospital me</td><td>Drug therapy of peptic ulcer disease.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40914367/" target="_blank">40914367</a></td><td>2025</td><td>Article</td><td>International journal of biolo</td><td>Famotidine-loaded chitosan hybridized fibroin nanoparticles exhibit outstanding ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25926722/" target="_blank">25926722</a></td><td>2015</td><td>Article</td><td>Drug design, development and t</td><td>Evaluation of combined famotidine with quercetin for the treatment of peptic ulc...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1764869/" target="_blank">1764869</a></td><td>1991</td><td>Article</td><td>Clinical pharmacokinetics</td><td>Clinical pharmacokinetics of famotidine.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16437673/" target="_blank">16437673</a></td><td>2005</td><td>Article</td><td>World journal of gastroenterol</td><td>Synergistic action of famotidine and chlorpheniramine on acetic acid-induced chr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2901868/" target="_blank">2901868</a></td><td>1988</td><td>Article</td><td>Bailliere&#x27;s clinical gastroent</td><td>Histamine H2-receptor antagonists.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2883883/" target="_blank">2883883</a></td><td>1987</td><td>Article</td><td>The American journal of gastro</td><td>Effect of famotidine on hepatic hemodynamics and peptic ulcer.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7594320/" target="_blank">7594320</a></td><td>1995</td><td>Article</td><td>Journal of clinical gastroente</td><td>Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazol...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1428035/" target="_blank">1428035</a></td><td>1992</td><td>Article</td><td>Indian journal of gastroentero</td><td>Comparative study of omeprazole and famotidine in the treatment of duodenal ulce...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2210613/" target="_blank">2210613</a></td><td>1990</td><td>Article</td><td>Hepato-gastroenterology</td><td>Effects of hepatic disease on the pharmacokinetics of famotidine and effects of ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2889257/" target="_blank">2889257</a></td><td>1987</td><td>Article</td><td>Scandinavian journal of gastro</td><td>Clinical benefits of intravenously administered famotidine in the treatment of u...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7594335/" target="_blank">7594335</a></td><td>1995</td><td>Article</td><td>Journal of clinical gastroente</td><td>Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultras...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. multiple endocrine neoplasia</span>
<span class="evidence-badge evidence-L2">L2</span>
<span class="prediction-score">99.69%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ3 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05417594" target="_blank">NCT05417594</a></td><td>PHASE1, PHASE2</td><td>RECRUITING</td><td>695</td><td>A Modular Phase I/IIa, Open-label, Multi-centre Study to Assess the Safety, Tole...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01248962" target="_blank">NCT01248962</a></td><td>PHASE2</td><td>COMPLETED</td><td>146</td><td>Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00451880" target="_blank">NCT00451880</a></td><td>PHASE1</td><td>COMPLETED</td><td>180</td><td>A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL281 Admi...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ1 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2874977/" target="_blank">2874977</a></td><td>1986</td><td>Article</td><td>Drugs</td><td>Current management of Zollinger-Ellison syndrome.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. acne (disease)</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.55%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

Famotidine åœ¨å°ç£æœ‰å¤šç¨®åŠ‘å‹å’Œå“ç‰Œä¸Šå¸‚ï¼š

| è¨±å¯è­‰å­—è™Ÿ | ä¸­æ–‡å“å | åŠ‘å‹ | è¨±å¯è­‰æŒæœ‰è€… | ç‹€æ…‹ |
|-----------|---------|------|-------------|------|
| è¡›ç½²è—¥è£½å­—ç¬¬037684è™Ÿ | è«¾å¾—èˆ’èƒƒç¦æ²»æ½°è†œè¡£éŒ 40æ¯«å…‹ | è†œè¡£éŒ  | ç´„å…‹è£½è—¥è‚¡ä»½æœ‰é™å…¬å¸ | æœ‰æ•ˆ |
| è¡›ç½²è—¥è£½å­—ç¬¬034815è™Ÿ | èƒƒåº·èˆ’è†œè¡£éŒ 20æ¯«å…‹ | è†œè¡£éŒ  | æ°¸ä¿¡è—¥å“å·¥æ¥­è‚¡ä»½æœ‰é™å…¬å¸ | æœ‰æ•ˆ |
| è¡›ç½²è—¥è£½å­—ç¬¬036152è™Ÿ | æ³•ç‘ªä¹³é “è† å›Š20æ¯«å…‹ | è† å›Š | ä¸­åœ‹åŒ–å­¸è£½è—¥è‚¡ä»½æœ‰é™å…¬å¸ | æœ‰æ•ˆ |

**åŠ‘å‹å¤šæ¨£**ï¼šéŒ åŠ‘ã€è† å›Šã€æ³¨å°„åŠ‘ã€å£æº¶éŒ ç­‰

## å®‰å…¨æ€§è€ƒé‡

### å·²çŸ¥é¢¨éšª
- **æ•´é«”å®‰å…¨æ€§è‰¯å¥½**ï¼šH2 æ‹®æŠ—åŠ‘æ˜¯æœ€å®‰å…¨çš„æŠ‘é…¸è—¥ç‰©ä¹‹ä¸€
- **é ­ç—›**ï¼šæœ€å¸¸è¦‹çš„å‰¯ä½œç”¨(ç´„ 4%)
- **è…¸èƒƒä¸é©**ï¼šä¾¿ç§˜ã€è…¹ç€‰
- **è¡€æ¶²å­¸ç•°å¸¸**ï¼šç½•è¦‹çš„è¡€å°æ¿æ¸›å°‘ç—‡

### è—¥ç‰©äº¤äº’ä½œç”¨
æ ¹æ“š DDInter è³‡æ–™åº«ï¼š

| äº¤äº’ä½œç”¨è—¥ç‰© | åš´é‡åº¦ | èªªæ˜ |
|-------------|--------|------|
| Ketoconazole | Moderate | æ¸›å°‘ ketoconazole å¸æ”¶ |
| Atazanavir | Major | æ¸›å°‘ atazanavir å¸æ”¶ï¼Œé¿å…ä½µç”¨ |
| Delavirdine | Major | æ¸›å°‘ delavirdine å¸æ”¶ |
| Dasatinib | Moderate | å¯èƒ½æ¸›å°‘å¸æ”¶ |

### ç‰¹æ®Šæ—ç¾¤
- **å­•å©¦**ï¼šB ç´šï¼Œç›¸å°å®‰å…¨
- **å“ºä¹³**ï¼šåˆ†æ³Œè‡³ä¹³æ±ï¼Œå»ºè­°è¬¹æ…ä½¿ç”¨
- **è…åŠŸèƒ½ä¸å…¨**ï¼šCrCl < 50 mL/min éœ€æ¸›é‡
- **è€å¹´äºº**ï¼šä¸€èˆ¬ç„¡éœ€èª¿æ•´åŠ‘é‡

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

**å’–å•¡å› ï¼ˆå’–å•¡ã€èŒ¶ã€å¯æ¨‚ï¼‰** ğŸŸ¢ Minor
- å½±éŸ¿ï¼šH2 é˜»æ–·åŠ‘å¯èƒ½å¢åŠ å’–å•¡å› å¸æ”¶
- å»ºè­°ï¼šç„¡éœ€ç‰¹åˆ¥é™åˆ¶


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**è…è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- å¯èƒ½éœ€è¦èª¿æ•´åŠ‘é‡ã€‚é¢¨éšªåŒ…æ‹¬ï¼šç™²ç™‡ç™¼ä½œã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

**Peptic Ulcer Hemorrhage** ğŸŸ¢ Minor
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### æ•´é«”è©•ä¼°
æ­¤é æ¸¬**å·²æœ‰å……åˆ†è‡¨åºŠè­‰æ“šæ”¯æŒ**ï¼ŒåŸå› å¦‚ä¸‹ï¼š
1. é æ¸¬é©æ‡‰ç—‡èˆ‡åŸæ ¸å‡†é©æ‡‰ç—‡é«˜åº¦é‡ç–Š
2. æœ‰å¤šå€‹ RCT å’Œç³»çµ±æ€§å›é¡§æ”¯æŒ
3. è—¥ç†æ©Ÿè½‰æ˜ç¢º
4. é•·æœŸå®‰å…¨æ€§è³‡æ–™å®Œæ•´

### å»ºè­°è¡Œå‹•
- [x] é€™äº›é©æ‡‰ç—‡åœ¨è‡¨åºŠå¯¦å‹™ä¸­å·²è¢«å»£æ³›ä½¿ç”¨
- [ ] å¯è€ƒæ…®å‘ TFDA ç”³è«‹é©æ‡‰ç—‡æ“´å±•ï¼ˆå¦‚æ˜ç¢ºçš„ã€ŒåäºŒæŒ‡è…¸èƒƒé€†æµã€é©æ‡‰ç—‡ï¼‰
- [ ] æŒçºŒç›£æ¸¬é•·æœŸä½¿ç”¨çš„å®‰å…¨æ€§

### è‡¨åºŠå»ºè­°
Famotidine å¯å®‰å…¨ç”¨æ–¼ï¼š
- è¼•è‡³ä¸­åº¦æ¶ˆåŒ–æ€§æ½°ç˜
- NSAID ç›¸é—œæ½°ç˜çš„é é˜²
- èƒƒé£Ÿé“é€†æµç–¾ç—…
- æ‡‰æ¿€æ€§æ½°ç˜é é˜²

å°æ–¼è¼ƒåš´é‡çš„ç—…ä¾‹ï¼Œå¯è€ƒæ…®ä½¿ç”¨ PPI é¡è—¥ç‰©ã€‚

### é¢¨éšªç­‰ç´š
**ä½é¢¨éšª** - å¯åœ¨é©ç•¶é©æ‡‰ç—‡ä¸‹å®‰å…¨ä½¿ç”¨

---

*å ±å‘Šç”Ÿæˆæ—¥æœŸï¼š2026-02-11*
*è³‡æ–™ä¾†æºï¼šTxGNN é æ¸¬ã€ClinicalTrials.govã€PubMedã€TFDA*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Urea]({{ "/drugs/urea/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Alprostadil]({{ "/drugs/alprostadil/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Threonine]({{ "/drugs/threonine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Levamisole]({{ "/drugs/levamisole/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Tioconazole]({{ "/drugs/tioconazole/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Famotidineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/famotidine/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_famotidine,
  title = {Famotidineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/famotidine/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
